首页 / 院系成果 / 成果详情页

Biomarker-Directed Sintilimab Monotherapy/combo in Untreated Advanced NSCLC: A Phase II Umbrella Trial (CTONG1702)  会议论文  

  • 编号:
    D3AEF866F293A7D40BF54E691969A8A2
  • 作者:
    Liu, S. y. m.[1] Du, Y. y.[2] Rui, X. c.[1] Dong, X. r.[3] Bai, X. y.[1] Sun, Y. l.[1] Cui, J. w.[4] Wang, B. h.[5] Ma, R.[6] Cang, S. d.[7] Chen, J. Y.[8] Wu, Y. l.[1] Zhou, Q.[1]
  • 语种:
    英文
  • 会议名称:
    JOURNAL OF THORACIC ONCOLOGY
  • 收录:
  • 推荐引用方式
    GB/T 7714:
    Liu S. -y. m.,Du Y. -y.,Rui X. -c., et al. Biomarker-Directed Sintilimab Monotherapy/combo in Untreated Advanced NSCLC: A Phase II Umbrella Trial (CTONG1702) [J].JOURNAL OF THORACIC ONCOLOGY,2026,21(10):S132-S132.
  • APA:
    Liu S. -y. m.,Du Y. -y.,Rui X. -c.,Dong X. -r.,&Zhou Q..(2026).Biomarker-Directed Sintilimab Monotherapy/combo in Untreated Advanced NSCLC: A Phase II Umbrella Trial (CTONG1702) .JOURNAL OF THORACIC ONCOLOGY,21(10):S132-S132.
  • MLA:
    Liu S. -y. m., et al. "Biomarker-Directed Sintilimab Monotherapy/combo in Untreated Advanced NSCLC: A Phase II Umbrella Trial (CTONG1702)" .JOURNAL OF THORACIC ONCOLOGY 21,10(2026):S132-S132.
  • 入库时间:
    11/22/2026 9:15:06 PM
  • 更新时间:
    11/23/2026 1:27:14 AM
浏览次数:3 下载次数:0
浏览次数:3
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部